Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Abecassis

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Viruses|May 24, 2013
Epigenetic control of cytomegalovirus latency and reactivationXue-feng Liu, Xueqiong Wang, Shixian Yan, et al.
Transplantation|August 3, 2021
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression SignatureJosh Levitsky, Manoj Kandpal, Kexin Guo, et al.
Hepatology (Baltimore, Md.)|April 20, 2019
External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver TransplantationJosh Levitsky, Sumeet K Asrani, Michael Abecassis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2011
Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?David Grant, Robert A Fisher, Michael Abecassis, et al.
Journal of Clinical Gastroenterology|December 13, 2007
Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndromeAndres T Blei, Sameer Mazhar, Charles J Davidson, et al.
Journal of the American College of Surgeons|March 2, 2005
Laparoscopic liver resectionJoseph F Buell, Alan J Koffron, Mark J Thomas, et al.
Human Immunology|January 15, 2009
Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agentsJosh Levitsky, Joshua Miller, Edward Wang, et al.
Transplantation|February 16, 2006
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipientsLorenzo Gallon, Enver Akalin, Patrick Lynch, et al.
Transplantation|October 24, 2019
Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related DeathNikhilesh R Mazumder, Kofi Atiemo, Amna Daud, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 10, 2005
Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoterSoo Jung Kim, Thomas K Varghese, Zheng Zhang, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Viruses|May 24, 2013
Epigenetic control of cytomegalovirus latency and reactivationXue-feng Liu, Xueqiong Wang, Shixian Yan, et al.
Transplantation|August 3, 2021
Prediction of Liver Transplant Rejection With a Biologically Relevant Gene Expression SignatureJosh Levitsky, Manoj Kandpal, Kexin Guo, et al.
Hepatology (Baltimore, Md.)|April 20, 2019
External Validation of a Pretransplant Biomarker Model (REVERSE) Predictive of Renal Recovery After Liver TransplantationJosh Levitsky, Sumeet K Asrani, Michael Abecassis, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 3, 2011
Should the liver transplant criteria for hepatocellular carcinoma be different for deceased donation and living donation?David Grant, Robert A Fisher, Michael Abecassis, et al.
Journal of Clinical Gastroenterology|December 13, 2007
Hemodynamic evaluation before liver transplantation: insights into the portal hypertensive syndromeAndres T Blei, Sameer Mazhar, Charles J Davidson, et al.
Journal of the American College of Surgeons|March 2, 2005
Laparoscopic liver resectionJoseph F Buell, Alan J Koffron, Mark J Thomas, et al.
Human Immunology|January 15, 2009
Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agentsJosh Levitsky, Joshua Miller, Edward Wang, et al.
Transplantation|February 16, 2006
ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipientsLorenzo Gallon, Enver Akalin, Patrick Lynch, et al.
Transplantation|October 24, 2019
Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related DeathNikhilesh R Mazumder, Kofi Atiemo, Amna Daud, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 10, 2005
Renal ischemia/reperfusion injury activates the enhancer domain of the human cytomegalovirus major immediate early promoterSoo Jung Kim, Thomas K Varghese, Zheng Zhang, et al.
Pageof 12